Eterna Therapeutics (NASDAQ:ERNA) Trading Up 0.5% – Still a Buy?

Eterna Therapeutics Inc. (NASDAQ:ERNA) shot up 0.5% during mid-day trading on Wednesday . The stock traded as high as $0.33 and last traded at $0.30. 176,706 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 17,227,727 shares. The stock had previously closed at $0.29.

Eterna Therapeutics Trading Up 0.5 %

The company’s fifty day simple moving average is $0.35 and its 200 day simple moving average is $0.83. The stock has a market capitalization of $1.60 million, a P/E ratio of -0.04 and a beta of 4.29.

Institutional Investors Weigh In On Eterna Therapeutics

An institutional investor recently raised its position in Eterna Therapeutics stock. Geode Capital Management LLC raised its holdings in Eterna Therapeutics Inc. (NASDAQ:ERNA) by 1,159.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 257,310 shares of the company’s stock after acquiring an additional 236,875 shares during the period. Geode Capital Management LLC owned approximately 4.76% of Eterna Therapeutics worth $76,000 at the end of the most recent reporting period. Institutional investors own 70.55% of the company’s stock.

Eterna Therapeutics Company Profile

Eterna Therapeutics Inc, a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.